Article ; Online: Leydig stem cells and future therapies for hypogonadism.
Current opinion in endocrinology, diabetes, and obesity
2020 Volume 27, Issue 6, Page(s) 419–423
Abstract: Purpose of review: In this review, we outline the most recent advances in the development of Leydig stem cells (LSCs) and summarize the current and upcoming treatments for hypogonadism.: Recent findings: In-vitro and in-vivo studies show that ... ...
Abstract | Purpose of review: In this review, we outline the most recent advances in the development of Leydig stem cells (LSCs) and summarize the current and upcoming treatments for hypogonadism. Recent findings: In-vitro and in-vivo studies show that inducing stem cells to differentiate into testosterone-producing adult Leydig cells is possible. In addition, LSCs can be grafted with Sertoli cells to increase testosterone levels in vivo. This therapy causes minimal effects on luteinizing hormone and follicle stimulating hormone levels. Novel therapies for hypogonadism include varying methods of testosterone delivery such as intranasal and oral agents, as well as novel selective estrogen and androgen receptor modulators. Summary: LSC therapies provide an effective way of increasing testosterone levels without detrimentally affecting gonadotropin levels. Next steps in developing viable Leydig cell grafting options for the treatment of hypogonadism should include the assessment of efficacy and potency of current animal models in human trials. Recently, both intranasal and oral testosterone have been made available and shown promising results in treating hypogonadism while maintaining fertility. Enclomiphene citrate and selective androgen receptor modulators have been suggested as future therapies for hypogonadism; however, further studies assessing efficacy and adverse effects are needed. |
---|---|
MeSH term(s) | Adult ; Animals ; Cell Differentiation/drug effects ; Fertility/physiology ; Humans ; Hypogonadism/therapy ; Leydig Cells/cytology ; Leydig Cells/physiology ; Leydig Cells/transplantation ; Male ; Stem Cell Transplantation/methods ; Stem Cell Transplantation/trends ; Stem Cells/physiology ; Testosterone/therapeutic use |
Chemical Substances | Testosterone (3XMK78S47O) |
Language | English |
Publishing date | 2020-10-01 |
Publishing country | England |
Document type | Journal Article ; Review |
ZDB-ID | 2272017-0 |
ISSN | 1752-2978 ; 1752-296X |
ISSN (online) | 1752-2978 |
ISSN | 1752-296X |
DOI | 10.1097/MED.0000000000000580 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Se 1363: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.